Active Ingredient (In Each Chewable Tablet)
Meclizine HCl 25 mg
The following Structured Product Label (SPL) was submitted to the FDA by Amerisource Bergen for the product Motion Sickness Relief (NDC 46122-774). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each chewable tablet), purpose, uses, do not use, ask a doctor before use if you have, ask a doctor or pharmacist before use if you are, when using this product, if pregnant or breast-feeding,, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Meclizine HCl 25 mg
Antiemetic
for prevention and treatment of nausea, vomiting, or dizziness associated with motion sickness
for children under 12 years of age unless directed by a doctor.
taking sedatives or tranquilizers.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away.
colloidal silicon dioxide, dextrose, FD&C red #40 aluminum lake, flavor, lactose monohydrate, magnesium stearate, pregelatinized starch, propylene glycol, saccharin sodium, silicon dioxide
1-800-426-9391
GOOD
NEIGHBOR
PHARMACY®
*Compare to the active ingredient in Bonine® Chewable Tablets
NDC 46122-774-51
Motion Sickness Relief
Meclizine HCl 25 mg Chewable Tablets / Antiemetic
Relief for up to 24 hours
Helps Prevent Nausea, Vomiting and Dizziness
due to Motion Sickness for up to 24 hours
Ages 12 Years and Over
Chew or crush tablets
completely before swallowing.
Do not swallow tablets whole.
Raspberry Flavored
Actual Size
16 Tablets 25 mg Each
TAMPER EVIDENT: DO NOT USE IF PACKAGE IS OPENED OR IF BLISTER
UNIT IS TORN, BROKEN OR SHOWS ANY SIGNS OF TAMPERING
AmerisourceBergen
1 West First Avenue
Conshohocken, PA 19428
Questions or Concerns?
www.mygnp.com
*This product is not manufactured or distributed by WellSpring
Pharmaceutical Corporation, owner of the registered trademark
Bonine® Chewable Tablets. 50844 ORG082340421
* Please review the disclaimer below.